Planning approved for bioscience development
Source: RNS
18th May 2023
THE CONYGAR INVESTMENT COMPANY PLC
Planning approved for bioscience development
at The Island Quarter, Nottingham
The Conygar Investment Company PLC ("Conygar") is pleased to announce that Nottingham City Council has approved its detailed application for the next phase of The Island Quarter development in Nottingham. The application comprises a 23,123 sq.m. (249,000 sq.ft.) bioscience building, which includes both laboratory and office space. The permission is subject to the documenting of the section 106 agreement.
Robert Ware, Chief Executive of Conygar, commented:
"We are delighted that the next phase of development has been approved. Nottingham is already home to a large number of exciting businesses in the bioscience space and this scheme will be an excellent addition to the mixed-use development we are creating at The Island Quarter".
Enquiries:
The Conygar Investment Company PLC
Robert Ware: 020 7258 8670
Liberum Capital Limited (Nominated Adviser and Broker)
Richard Lindley: 020 3100 2185
Temple Bar Advisory (Public Relations)
Alex Child-Villiers: 07795 425580
William Barker: 07827 960151
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
